Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keigo Endo

Showing results (91-100 of 171) with videos related to

Pageof 18
Sort By:
Annals of Nuclear Medicine|February 1, 2006
PET evaluation of fatty tumors in the extremity: possibility of using the standardized uptake value (SUV) to differentiate benign tumors from liposarcomaRyoko Suzuki, Hideomi Watanabe, Takashi Yanagawa, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|July 30, 2009
[Application of 18F-FDG PET for the assessment of early response to the treatment and prognosis of patients]Noboru Oriuchi, Tetsuya Higuchi, Keigo Endo, et al.
Academic Radiology|February 20, 2007
Inverse correlation between tumor perfusion and glucose uptake in human head and neck tumorsSatoshi Hirasawa, Yoshito Tsushima, Hiroyuki Takei, et al.
Annals of Nuclear Medicine|November 9, 2022
Comparative evaluation of radionuclide therapy using <sup>90</sup>Y and <sup>177</sup>LuHirofumi Hanaoka, Kazuyuki Hashimoto, Satoshi Watanabe, et al.
Academic Radiology|April 17, 2007
Perfusion CT of breast carcinoma: arterial perfusion of nonscirrhous carcinoma was higher than that of scirrhous carcinomaHiromi Hirasawa, Yoshito Tsushima, Satoshi Hirasawa, et al.
Acta Dermato-Venereologica|November 13, 2008
Nephrogenic systemic fibrosis with multiple calcification and osseous metaplasiaYayoi Nagai, Michiko Hasegawa, Kahori Shinmi, et al.
Cancer Science|December 1, 2011
Predicting cetuximab accumulation in KRAS wild-type and KRAS mutant colorectal cancer using 64Cu-labeled cetuximab positron emission tomographyArifudin Achmad, Hirofumi Hanaoka, Hiroki Yoshioka, et al.
Annals of Nuclear Medicine|August 16, 2005
Hexokinase-II expression in untreated oral squamous cell carcinoma: comparison with FDG PET imagingMei Tian, Hong Zhang, Tetsuya Higuchi, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 5, 2013
Fractionated radioimmunotherapy with ⁹⁰Y-labeled fully human anti-CEA antibodyHirofumi Hanaoka, Masahide Kuroki, Aiko Yamaguchi, et al.
Annals of Nuclear Medicine|February 6, 2008
Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinomaBishnuhari Paudyal, Noboru Oriuchi, Pramila Paudyal, et al.
Pageof 18

Showing results (91-100 of 171) with videos related to

Sort By:
Pageof 18
Annals of Nuclear Medicine|February 1, 2006
PET evaluation of fatty tumors in the extremity: possibility of using the standardized uptake value (SUV) to differentiate benign tumors from liposarcomaRyoko Suzuki, Hideomi Watanabe, Takashi Yanagawa, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|July 30, 2009
[Application of 18F-FDG PET for the assessment of early response to the treatment and prognosis of patients]Noboru Oriuchi, Tetsuya Higuchi, Keigo Endo, et al.
Academic Radiology|February 20, 2007
Inverse correlation between tumor perfusion and glucose uptake in human head and neck tumorsSatoshi Hirasawa, Yoshito Tsushima, Hiroyuki Takei, et al.
Annals of Nuclear Medicine|November 9, 2022
Comparative evaluation of radionuclide therapy using <sup>90</sup>Y and <sup>177</sup>LuHirofumi Hanaoka, Kazuyuki Hashimoto, Satoshi Watanabe, et al.
Academic Radiology|April 17, 2007
Perfusion CT of breast carcinoma: arterial perfusion of nonscirrhous carcinoma was higher than that of scirrhous carcinomaHiromi Hirasawa, Yoshito Tsushima, Satoshi Hirasawa, et al.
Acta Dermato-Venereologica|November 13, 2008
Nephrogenic systemic fibrosis with multiple calcification and osseous metaplasiaYayoi Nagai, Michiko Hasegawa, Kahori Shinmi, et al.
Cancer Science|December 1, 2011
Predicting cetuximab accumulation in KRAS wild-type and KRAS mutant colorectal cancer using 64Cu-labeled cetuximab positron emission tomographyArifudin Achmad, Hirofumi Hanaoka, Hiroki Yoshioka, et al.
Annals of Nuclear Medicine|August 16, 2005
Hexokinase-II expression in untreated oral squamous cell carcinoma: comparison with FDG PET imagingMei Tian, Hong Zhang, Tetsuya Higuchi, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 5, 2013
Fractionated radioimmunotherapy with ⁹⁰Y-labeled fully human anti-CEA antibodyHirofumi Hanaoka, Masahide Kuroki, Aiko Yamaguchi, et al.
Annals of Nuclear Medicine|February 6, 2008
Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinomaBishnuhari Paudyal, Noboru Oriuchi, Pramila Paudyal, et al.
Pageof 18